As of Sep 04
| -0.01 / -0.40%|
The 1 analysts offering 12-month price forecasts for Rosetta Genomics Ltd have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +103.25% increase from the last price of 2.46.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.